Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Yabe

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2021
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 casesHong Fang, Mariko Yabe, Xiaohui Zhang, et al.
Human Pathology|March 22, 2016
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patientsMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
The American Journal of Surgical Pathology|February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 CasesMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Science Translational Medicine|June 11, 2025
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosisShenghuan Sun, Zhanghan Yin, Jacob G Van Cleave, et al.
Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Research Square|November 24, 2025
Interpretable Multiple Instance Learning for Hematologic Diagnosis from Peripheral Blood SmearsSiddharth Singi, Shenghuan Sun, Zhanghan Yin, et al.
Communications Medicine|April 14, 2026
Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smearsSiddharth Singi, Shenghuan Sun, Zhanghan Yin, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2021
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 casesHong Fang, Mariko Yabe, Xiaohui Zhang, et al.
Human Pathology|March 22, 2016
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patientsMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
The American Journal of Surgical Pathology|February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 CasesMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Science Translational Medicine|June 11, 2025
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosisShenghuan Sun, Zhanghan Yin, Jacob G Van Cleave, et al.
Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Research Square|November 24, 2025
Interpretable Multiple Instance Learning for Hematologic Diagnosis from Peripheral Blood SmearsSiddharth Singi, Shenghuan Sun, Zhanghan Yin, et al.
Communications Medicine|April 14, 2026
Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smearsSiddharth Singi, Shenghuan Sun, Zhanghan Yin, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
Pageof 6